Abstract
The purpose of this work was to investigate the relationship of gonadotropin levels to body weight and insulin levels in women with polycystic ovary syndrome (PCOS). Specifically, we wished to test the hypothesis that circulating luteinizing hormone (LH) and insulin levels are different in obese and normal weight patients with PCOS. The basal plasma levels of gonadotropins, estrogens, androgens and sex hormone-binding globulin, the gonadotropin responses to gonadotropin releasing hormone (GnRH) and the insulin and C-peptide responses to a 3-hour oral glucose tolerance test (OGTT) were measured in 19 obese and 19 normal weight patients with PCOS and 7 obese and 8 normal weight ovulatory controls. Data of the patients were evaluated according to body weight (obese vs normal weight) and basal LH (high vs normal). There was no significant difference in basal LH and androgen levels and in the insulin response to oral glucose between obese and normal weight patients with PCOS. Compared to the weight matched controls, both obese and non obese patients showed significantly higher LH responses to GnRH and C-peptide responses to OGTT. When the high LH patients (no=18) were compared those with normal LH (no=20), the high LH subjects exhibited significantly higher androstenedione levels. Both obese (no=10) and normal weight (no=8) patients with high LH showed significantly greater C-peptide responses to OGTT than obese (no=9) and non obese (no=11) patients with normal LH. However, as compared with the weight matched controls, both the high LH and normal LH patients had significantly greater C-peptide responses to OGTT. We conclude that obese and non obese patients with PCOS do not seem to differ in the prevalence of elevated LH levels or in the LH secretory pattern. Insulin resistance, expressed by an enhanced pancreatic sensitivity to oral glucose, is present in both the high LH and the normal LH subjects, even though the PCOS patients with elevated LH tend to be more insulin resistant and hyperandrogenic than the normal LH patients.
Similar content being viewed by others
References
Conway G.S., Honour J.W., Jacobs H.S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound feature in 556 patients. Clin. Endocrinol. (Oxf.) 30: 459, 1989.
Conway S.G., Jacobs H.S., Holly J.M.P., Wass J.A.M. Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 33: 593, 1990.
Kiddy D.S., Sharp P.S., White D.M., Scanion M.F., Mason H.D., Bracy C.S. Differences in clinical and endocrine features between obese and non obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol. (Oxf.) 32: 213, 1990.
Daniel S.G., Kistner R.W., Ryan K.S. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 62: 904, 1986.
Anttilla L., Ding Y-A., Ruutiainen K., Erkkola R., Irjala K., Huhtaniemi I. Clinical features and circulating gonadotropin insulin and androgen interactions in women with polycystic ovarian disease. Fertil. Steril. 55: 1057, 1991.
Dale P.O., Tanbo T., Vaaler S., Abyholm T. Body weight, hyperinsulinemia and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril. 58: 487, 1992.
Dunaif A., Mandeli J., Fluhr H., Dobriansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 66: 131, 1988.
Franks S. Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.) 31: 87, 1989.
Nestler J.E., Clore J.N., Blackard W.G. The central role of obesity (o hyperinsulinemia) in the pathogenesis of the polycistic ovary syndrome. Am. J. Obstet. Gynecol. 161: 1095, 1989.
Tropeano G., Lucisano A., Liberale I., Barini A., Vuolo I.P., Martino G., Menini E., Dell’Acqua S. Insulin, C-peptide, androgens and Beta-Endorphin response to oral glucose in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 78: 305, 1994.
Ardaens Y., Robert Y., Le Maitre L., Fossati P., Dewailly D. Polycystic ovarian disease: contribution of vaginal endosonography and reassesment of ultrasonic diagnosis. Fertil. Steril. 55: 1062, 1991.
Goldzieher J.W., Dozier I.S., Smith K.D., Steinberg E.J. Improving the diagnostic reliability of rapidly fluctuating plasma-hormone levels by optimized multiplesamply techniques. J. Clin. Endocrinol. Metab. 43: 824, 1976.
Rebar R., Judd H.L., Yen S.S.C., Rakoff J., Vandenberg G., Naftolin B. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57: 1320, 1976.
Dunaif A., Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J. Clin. Invest. 83: 23, 1989.
Anttila L., Koskinen P., Jaatinen T-A., Erkkola R., Irjala K., Ruutiainen K. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum. Reprod. 8: 1179, 1993.
Polonsky K.S., Given B.D., Hirsch L. Quantitative study of insulin secretion and clearance in normal and obese subjects. J. Clin. Invest. 81:435, 1988.
Buyalos R.P., Geffner M.E., Watanabe R.M., Bergaman R.N., Gornbein J.A., Judd H.L. The influence of luteinizing hormone and insulin on sex steroid and sex hormone-binding globulin in the polycystic ovarian syndrome. Fertil. Steril. 60: 626, 1993.
Peiris A.N., Mueller R.A., Struve M.F., Smith G.A., Kissebah A.H. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. J. Clin. Endocrinol. Metab. 64: 162, 1987.
Adashi E.Y., Hsueh A.J.W., Yen S.S.C. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108: 1441, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tropeano, G., Vuolo, I.P., Lucisano, A. et al. Gonadotropin levels in women with polycystic ovary syndrome: Their relationship to body weight and insulin levels. J Endocrinol Invest 19, 139–145 (1996). https://doi.org/10.1007/BF03349856
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349856